Tag: Iron chelation

Without effective treatment, the progressive accumulation of excess iron can be fatal in patients with chronic anemia, underscoring the critical need for iron chelation therapy. The U.S. Food and Drug Administration (FDA) has approved three primary iron chelators to help remove this excess iron from the body and prevent organ damage. This guide provides a comprehensive overview of these crucial medications.

According to Safety Data Sheets, deferasirox is categorized as a hazardous chemical, requiring specific precautions for handling by healthcare workers,. Beyond occupational risks, the iron chelator also carries significant potential for serious, and sometimes fatal, adverse effects in patients, demanding rigorous clinical monitoring during treatment,.